Participants receive close monitoring, and outcomes dont always translate perfectly into everyday care
The highest studied dose showed major weight loss over 80 weeks
They often require continuous use to maintain weight loss, making them a lifelong commitment rather than a definitive solution
Patients are encouraged to speak with their GP or a specialist weight management service to explore currently available, approved treatment options
From these findings, the following hypothesis has been generated: stimulating the GLP-1 receptor with respective agonists has a potential to cause pancreatitis, perhaps chronic pancreatitis, and in the long term, potentially even pancreatic cancer (35)
Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J